- Contract Awards
Moderna (Nasdaq: MRNA) has secured a $3.3 billion contract modification from the U.S. Army for additional 200 million filled drug production doses of its SARS-CoV-2 mRNA-1273 vaccine, bringing the total confirmed government order to 500 million doses. The Department of Defense said Monday the biotechnology company will conduct production work at its...









